Your session is about to expire
← Back to Search
Anticoagulation Therapy Timing for Atrial Fibrillation After Subdural Hematoma (ATTAACH Trial)
ATTAACH Trial Summary
This trial will compare the outcomes of two different approaches to restarting anticoagulation in patients who have had surgery for subdural hematoma.
ATTAACH Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowATTAACH Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.ATTAACH Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I need surgery to relieve pressure inside my skull.I have a mechanical heart valve or significant narrowing of the heart's mitral valve.My doctor has chosen Warfarin over DOACs for preventing blood clots after my head injury.I am 18 years old or older.I can undergo surgery for drainage of a subdural hematoma.I am on blood thinners for stroke prevention due to atrial fibrillation.My recent brain scan shows I need surgery again for my condition.I have a specific type of brain bleed diagnosed by a CT scan.I have a long-term blood clotting issue that can't be corrected.I do not have active bleeding in my stomach, urinary tract, or lungs.I need blood thinners for a reason other than atrial fibrillation.
- Group 1: Early resumption of anticoagulation
- Group 2: Delayed resumption of anticoagulation
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there still openings for enrolment in this investigation?
"Affirmative. The information on clinicaltrials.gov suggests that the study is currently in search of participants, with its initial posting occurring on November 24th 2022 and latest revision made a few days later. A total of 120 individuals need to be recruited from 1 medical centre."
What are the research objectives of this investigation?
"Over the course of twelve months, primary efficacy endpoints include adherence to study protocol and secondary objectives include thromboembolic events (symptomatic TIA, ischemic stroke, systemic embolism), functional outcomes measured by NIHSS scale and modified Rankin Scale. The latter two measure neurological deficit severity and disability respectively; favourable outcome are ranked 0-3 on both scales while unfavourable ones range from 4-6."
To what extent is the patient cohort involved in this investigation?
"Affirmative. The official details on clinicaltrials.gov suggest that this medical trial is currently recruiting participants, and the listing was initially posted on November 24th 2022 with a most recent update occurring four days later. There are 120 openings for individuals at one specific location."
Share this study with friends
Copy Link
Messenger